CIK 0001159036
- Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880488686
- Phone
- +1 858-794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $21,662,139
- in 5 filings, $21.7M under 10b5-1 plans
Net −$21,662,139. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-15 | Torley Helen PRESIDENT AND CEO | Sale | −13 | $54.61 | $710 | 587,177 |
| 2022-11-15 | Torley Helen PRESIDENT AND CEO | Exercise or conversion · Option to Purchase Common Stock | −10,000 | $14.66 | $147K | 140,000 |
| 2022-11-15 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Sale | −4,635 | $53.82 | $249K | 4,410 |
| 2022-11-15 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Sale | −365 | $53.69 | $20K | 4,045 |
| 2022-11-15 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Sale | −6,877 | $54.12 | $372K | 166,260 |
| 2022-11-15 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Sale | −8 | $54.61 | $437 | 166,252 |
| 2022-11-15 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Sale | −3,115 | $54.14 | $169K | 163,137 |
| 2022-05-05 | Posard Matthew L. Director | Grant or award | +6,206 | 135,189 | ||
| 2022-05-05 | Miyashita Akiko Moni Director | Grant or award | +6,206 | 6,206 | ||
| 2022-05-05 | MATSUI CONNIE Director | Grant or award | +6,206 | 188,189 | ||
| 2022-05-05 | Henderson Jeffrey William Director | Grant or award | +6,206 | 59,045 | ||
| 2022-05-05 | Daly James M Director | Grant or award | +6,206 | 32,438 | ||
| 2022-05-05 | Connaughton Bernadette Director | Grant or award | +6,206 | 38,219 | ||
| 2022-05-05 | BIZZARI JEAN-PIERRE Director | Grant or award | +6,206 | 58,750 | ||
| 2022-02-16 | LaBarre Michael J. SVP, Chief Technical Officer | Grant or award · Option to Purchase Common Stock | +74,777 | 74,777 | ||
| 2022-02-16 | LaBarre Michael J. SVP, Chief Technical Officer | Grant or award · Restricted Stock Units | +24,448 | 24,448 | ||
| 2022-02-16 | LaBrosse Nicole SVP, Chief Financial Officer | Grant or award · Option to Purchase Common Stock | +62,315 | 62,315 | ||
| 2022-02-16 | LaBrosse Nicole SVP, Chief Financial Officer | Grant or award · Restricted Stock Units | +20,373 | 20,373 | ||
| 2022-02-16 | Torley Helen President and CEO | Grant or award · Option to Purchase Common Stock | +257,046 | 257,046 | ||
| 2022-02-16 | Torley Helen President and CEO | Grant or award · Restricted Stock Units | +84,037 | 84,037 |
Page 45 of 48 · 944 trades